Gulf Funds Agree to Back Paramount's Takeover of Warner; Netflix Upgraded; Neurocrine to Buy Soleno Therapeutics

Stock Movers

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Gulf Funds Agree to Back Paramount's $81 Billion Takeover of Warner

- Netflix (NFLX) shares are up after Goldman Sachs upgraded the streaming-video company to buy from neutral.

- Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion to expand in rare genetic disorders. The biotechnology company will pay $53 per share for Soleno, a 34% premium to its closing share price Thursday, using cash on hand and some pre-payable debt. Both company boards have approved the transaction, which is expected to close within 90 days.

See omnystudio.com/listener for privacy information.

More description

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Gulf Funds Agree to Back Paramount's $81 Billion Takeover of Warner

- Netflix (NFLX) shares are up after Goldman Sachs upgraded the streaming-video company to buy from neutral.

- Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion to expand in rare genetic disorders. The biotechnology company will pay $53 per share for Soleno, a 34% premium to its closing share price Thursday, using cash on hand and some pre-payable debt. Both company boards have approved the transaction, which is expected to close within 90 days.

See omnystudio.com/listener for privacy information.

2026-04-06 4 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.